CN117015619A - 头颈癌的诊断和风险确定 - Google Patents
头颈癌的诊断和风险确定 Download PDFInfo
- Publication number
- CN117015619A CN117015619A CN202180094731.5A CN202180094731A CN117015619A CN 117015619 A CN117015619 A CN 117015619A CN 202180094731 A CN202180094731 A CN 202180094731A CN 117015619 A CN117015619 A CN 117015619A
- Authority
- CN
- China
- Prior art keywords
- cancer
- patient
- nucleotide
- head
- methylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014829 head and neck neoplasm Diseases 0.000 title claims abstract description 69
- 201000010536 head and neck cancer Diseases 0.000 title claims abstract description 57
- 238000003745 diagnosis Methods 0.000 title description 5
- 230000011987 methylation Effects 0.000 claims abstract description 109
- 238000007069 methylation reaction Methods 0.000 claims abstract description 109
- 238000000034 method Methods 0.000 claims abstract description 89
- 101000782312 Homo sapiens Putative zinc finger protein 833 Proteins 0.000 claims abstract description 31
- 101000782302 Homo sapiens Zinc finger protein 823 Proteins 0.000 claims abstract description 29
- 108020004414 DNA Proteins 0.000 claims description 86
- 125000003729 nucleotide group Chemical group 0.000 claims description 61
- 239000002773 nucleotide Substances 0.000 claims description 60
- 206010028980 Neoplasm Diseases 0.000 claims description 52
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 239000012472 biological sample Substances 0.000 claims description 41
- 201000011510 cancer Diseases 0.000 claims description 36
- 210000001519 tissue Anatomy 0.000 claims description 30
- 210000003917 human chromosome Anatomy 0.000 claims description 25
- 101000915607 Homo sapiens Zinc finger protein 671 Proteins 0.000 claims description 22
- 102100023497 Zinc finger protein ZIC 1 Human genes 0.000 claims description 21
- 101000976653 Homo sapiens Zinc finger protein ZIC 1 Proteins 0.000 claims description 20
- 102100028943 Zinc finger protein 671 Human genes 0.000 claims description 20
- 108010032788 PAX6 Transcription Factor Proteins 0.000 claims description 19
- 102000007354 PAX6 Transcription Factor Human genes 0.000 claims description 18
- 210000000349 chromosome Anatomy 0.000 claims description 17
- 101000915603 Homo sapiens Zinc finger protein 773 Proteins 0.000 claims description 14
- 210000004027 cell Anatomy 0.000 claims description 14
- 102100028585 Zinc finger protein 773 Human genes 0.000 claims description 13
- 238000007855 methylation-specific PCR Methods 0.000 claims description 13
- 208000006842 Tonsillar Neoplasms Diseases 0.000 claims description 10
- 239000013068 control sample Substances 0.000 claims description 10
- 241001631646 Papillomaviridae Species 0.000 claims description 8
- 239000007850 fluorescent dye Substances 0.000 claims description 8
- 238000012216 screening Methods 0.000 claims description 8
- 206010044002 Tonsil cancer Diseases 0.000 claims description 7
- 210000000214 mouth Anatomy 0.000 claims description 6
- 210000002741 palatine tonsil Anatomy 0.000 claims description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 5
- 238000011161 development Methods 0.000 claims description 5
- 210000003296 saliva Anatomy 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 210000003238 esophagus Anatomy 0.000 claims description 4
- 238000007672 fourth generation sequencing Methods 0.000 claims description 4
- 210000003128 head Anatomy 0.000 claims description 4
- 210000003928 nasal cavity Anatomy 0.000 claims description 4
- 210000003739 neck Anatomy 0.000 claims description 4
- 210000003800 pharynx Anatomy 0.000 claims description 4
- 108091008146 restriction endonucleases Proteins 0.000 claims description 4
- 206010023825 Laryngeal cancer Diseases 0.000 claims description 3
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 3
- 210000000941 bile Anatomy 0.000 claims description 3
- 238000001574 biopsy Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 206010023841 laryngeal neoplasm Diseases 0.000 claims description 3
- 210000003079 salivary gland Anatomy 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- 210000003802 sputum Anatomy 0.000 claims description 3
- 208000024794 sputum Diseases 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 108091029430 CpG site Proteins 0.000 claims description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 2
- 208000003445 Mouth Neoplasms Diseases 0.000 claims description 2
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims description 2
- 208000010505 Nose Neoplasms Diseases 0.000 claims description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 2
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims description 2
- 206010061934 Salivary gland cancer Diseases 0.000 claims description 2
- 201000004101 esophageal cancer Diseases 0.000 claims description 2
- 201000006866 hypopharynx cancer Diseases 0.000 claims description 2
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 208000037830 nasal cancer Diseases 0.000 claims description 2
- 208000037968 sinus cancer Diseases 0.000 claims description 2
- 206010044285 tracheal cancer Diseases 0.000 claims description 2
- 102100021090 Homeobox protein Hox-A9 Human genes 0.000 claims 2
- 108010027263 homeobox protein HOXA9 Proteins 0.000 claims 2
- 206010043515 Throat cancer Diseases 0.000 claims 1
- 102100035789 Putative zinc finger protein 833 Human genes 0.000 abstract description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 10
- 239000000523 sample Substances 0.000 description 36
- 239000003550 marker Substances 0.000 description 29
- 241000701806 Human papillomavirus Species 0.000 description 18
- 238000001514 detection method Methods 0.000 description 15
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 14
- 108091029523 CpG island Proteins 0.000 description 12
- 239000013615 primer Substances 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 9
- 102100035804 Zinc finger protein 823 Human genes 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000006607 hypermethylation Effects 0.000 description 8
- 230000009826 neoplastic cell growth Effects 0.000 description 8
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 7
- 230000007067 DNA methylation Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 6
- -1 HOXA9 Proteins 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 5
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 101150008172 HOXA9 gene Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 206010033128 Ovarian cancer Diseases 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229940113082 thymine Drugs 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- XAUDJQYHKZQPEU-KVQBGUIXSA-N 5-aza-2'-deoxycytidine Chemical compound O=C1N=C(N)N=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 XAUDJQYHKZQPEU-KVQBGUIXSA-N 0.000 description 2
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 2
- 101710095339 Apolipoprotein E Proteins 0.000 description 2
- 102100027708 Astrotactin-1 Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108700005087 Homeobox Genes Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000936741 Homo sapiens Astrotactin-1 Proteins 0.000 description 2
- 101001110357 Homo sapiens Relaxin-3 receptor 1 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 101150081664 PAX6 gene Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 102100022105 Relaxin-3 receptor 1 Human genes 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 101150105200 ZNF773 gene Proteins 0.000 description 2
- 101150016852 Zic1 gene Proteins 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 229960002756 azacitidine Drugs 0.000 description 2
- ZETCGWYACBNPIH-UHFFFAOYSA-N azane;sulfurous acid Chemical compound N.OS(O)=O ZETCGWYACBNPIH-UHFFFAOYSA-N 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 229960003603 decitabine Drugs 0.000 description 2
- 238000007847 digital PCR Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101150070189 CIN3 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 102100032141 Cell death activator CIDE-A Human genes 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 208000030808 Clear cell renal carcinoma Diseases 0.000 description 1
- 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 description 1
- 102000012666 Core Binding Factor Alpha 3 Subunit Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000015883 Dact2 Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000003693 Hedgehog Proteins Human genes 0.000 description 1
- 108090000031 Hedgehog Proteins Proteins 0.000 description 1
- 102100035960 Hedgehog-interacting protein Human genes 0.000 description 1
- 101710164669 Hedgehog-interacting protein Proteins 0.000 description 1
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 description 1
- 102100039544 Homeobox protein Hox-D10 Human genes 0.000 description 1
- 101000775570 Homo sapiens Cell death activator CIDE-A Proteins 0.000 description 1
- 101000856025 Homo sapiens Dapper homolog 2 Proteins 0.000 description 1
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 description 1
- 101000962573 Homo sapiens Homeobox protein Hox-D10 Proteins 0.000 description 1
- 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
- 101000601647 Homo sapiens Paired box protein Pax-6 Proteins 0.000 description 1
- 101000831616 Homo sapiens Protachykinin-1 Proteins 0.000 description 1
- 101000652324 Homo sapiens Transcription factor SOX-17 Proteins 0.000 description 1
- 101000976643 Homo sapiens Zinc finger protein ZIC 2 Proteins 0.000 description 1
- 101000976642 Homo sapiens Zinc finger protein ZIC 4 Proteins 0.000 description 1
- 206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
- 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
- 102100032818 Integrin alpha-4 Human genes 0.000 description 1
- 208000035346 Margins of Excision Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
- 206010031112 Oropharyngeal squamous cell carcinoma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102100024304 Protachykinin-1 Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010043903 Tobacco abuse Diseases 0.000 description 1
- 102100030243 Transcription factor SOX-17 Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 102000013814 Wnt Human genes 0.000 description 1
- 108050003627 Wnt Proteins 0.000 description 1
- 101150042526 ZNF671 gene Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 101710185494 Zinc finger protein Proteins 0.000 description 1
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
- 102100023492 Zinc finger protein ZIC 2 Human genes 0.000 description 1
- 102100023493 Zinc finger protein ZIC 4 Human genes 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 108091092240 circulating cell-free DNA Proteins 0.000 description 1
- 206010073251 clear cell renal cell carcinoma Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000006718 epigenetic regulation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000004766 neurogenesis Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 201000011330 nonpapillary renal cell carcinoma Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 201000006958 oropharynx cancer Diseases 0.000 description 1
- 208000022698 oropharynx squamous cell carcinoma Diseases 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 208000023747 urothelial carcinoma Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
- C12Q2521/331—Methylation site specific nuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/054926 WO2022179708A1 (en) | 2021-02-26 | 2021-02-26 | Diagnosis and risk determination for head and neck cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117015619A true CN117015619A (zh) | 2023-11-07 |
Family
ID=74856832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180094731.5A Pending CN117015619A (zh) | 2021-02-26 | 2021-02-26 | 头颈癌的诊断和风险确定 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4298249A1 (ko) |
| JP (1) | JP2024511561A (ko) |
| KR (1) | KR20230154009A (ko) |
| CN (1) | CN117015619A (ko) |
| AU (1) | AU2021429371A1 (ko) |
| CA (1) | CA3208505A1 (ko) |
| WO (1) | WO2022179708A1 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117625791A (zh) * | 2024-01-23 | 2024-03-01 | 杭州华得森生物技术有限公司 | 用于结直肠癌诊断和预后判断的生物标志物及其应用 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116574810B (zh) * | 2023-07-05 | 2023-10-13 | 广州凯普医药科技有限公司 | 一种通过检测znf671和zmynd10基因甲基化诊断鼻咽癌的试剂盒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2308998A1 (de) | 2009-09-18 | 2011-04-13 | Universitätsklinikum Jena Körperschaft des öffentlichen Rechts und Teilkörperschaft der Friedrich-Schiller-Universität Jena | Verfahren zur frühen Diagnose von Karzinomen des Anogenitaltraktes |
| US10961590B2 (en) * | 2015-09-17 | 2021-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cancer detection methods |
| AU2019200359A1 (en) * | 2019-01-18 | 2020-09-10 | Clinical Genomics Pty Ltd | Screening method |
| US20200299779A1 (en) * | 2019-02-13 | 2020-09-24 | Epigenomics Ag | Methods for detecting head and neck cancer |
-
2021
- 2021-02-26 EP EP21709633.8A patent/EP4298249A1/en active Pending
- 2021-02-26 KR KR1020237028775A patent/KR20230154009A/ko active Search and Examination
- 2021-02-26 AU AU2021429371A patent/AU2021429371A1/en active Pending
- 2021-02-26 CA CA3208505A patent/CA3208505A1/en active Pending
- 2021-02-26 WO PCT/EP2021/054926 patent/WO2022179708A1/en active Application Filing
- 2021-02-26 CN CN202180094731.5A patent/CN117015619A/zh active Pending
- 2021-02-26 JP JP2023551997A patent/JP2024511561A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117625791A (zh) * | 2024-01-23 | 2024-03-01 | 杭州华得森生物技术有限公司 | 用于结直肠癌诊断和预后判断的生物标志物及其应用 |
| CN117625791B (zh) * | 2024-01-23 | 2024-04-16 | 杭州华得森生物技术有限公司 | 用于结直肠癌诊断和预后判断的生物标志物及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022179708A1 (en) | 2022-09-01 |
| CA3208505A1 (en) | 2022-09-01 |
| KR20230154009A (ko) | 2023-11-07 |
| AU2021429371A1 (en) | 2023-09-14 |
| US20240132968A1 (en) | 2024-04-25 |
| EP4298249A1 (en) | 2024-01-03 |
| JP2024511561A (ja) | 2024-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8785614B2 (en) | Aberrantly methylated genes in pancreatic cancer | |
| ES2533767T3 (es) | Métodos para el análisis de trastornos proliferativos celulares | |
| EP1527199B1 (en) | Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples | |
| US20150126374A1 (en) | Hypermethylated gene markers for head and neck cancer | |
| JP2010517582A (ja) | 結腸癌の早期検出および予後診断の方法 | |
| EP2906716B1 (en) | Hsa-mir124 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions | |
| US9096905B2 (en) | Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans | |
| CN106834426B (zh) | 用于检测胰腺癌的组合物及其用途 | |
| WO2021004215A1 (zh) | 一种多基因联合检测试剂 | |
| JP2022116131A (ja) | 新生物および癌のリスク決定 | |
| CN105331727A (zh) | 一种人外周血循环肿瘤DNA中septin 9基因甲基化的检测试剂盒 | |
| CN117015619A (zh) | 头颈癌的诊断和风险确定 | |
| KR20220032603A (ko) | 유전자 마커 조합 및 이의 용도 | |
| Longo et al. | Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma | |
| KR20230005927A (ko) | 종양 검출 시약 및 키트 | |
| WO2021003629A1 (en) | Methods and Compositions for Lung Cancer Detection | |
| CN116144782A (zh) | 一种用于肺癌检测的组合标志物及其应用 | |
| US20130288918A1 (en) | Colorectal Cancer Screening Method | |
| US20240229146A9 (en) | Diagnosis and risk determination for head and neck cancer | |
| KR20210013103A (ko) | 종양 마커, 메틸화 검출 시약, 키트 및 이의 용도 | |
| EP2922973A1 (en) | A method of detecting methylation | |
| RU2818527C1 (ru) | Реагент для обнаружения опухолей | |
| US20080213781A1 (en) | Methods of detecting methylation patterns within a CpG island | |
| CN117721207A (zh) | 用于检测宫颈癌和/或宫颈高级别病变的组合物及其用途 | |
| Class et al. | Patent application title: HYPERMETHYLATED GENE MARKERS FOR HEAD AND NECK CANCER Inventors: Joseph A. Califano (Baltimore, MD, US) Daria A. Gaykalova (Baltimore, MD, US) Assignees: THE JOHNS HOPKINS UNIVERSITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40102258 Country of ref document: HK |